Language

CAS No. 1029877-94-8 | Trelagliptin succinate

CAS No. 1029877-94-8 | Trelagliptin succinate

Name: Trelagliptin succinate CAS No.1029877-94-8 MF:C22H26FN5O6 MW:475.48 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery

Categories：

Biochemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 1029877-94-8 | Trelagliptin succinate

Synonyms:

SYR-472 succinate;

SYR-472 Trelagliptin succinat;

Trelagliptin succinate;

Trelagliptin succinate SYR 111472 succinate;

Telagliptin Succinate

Specification:

ITEMS	SPECIFICATION
CAS	1029877-94-8
MF	C22H26FN5O6
MW	475.48
Color	White solid
Solubility	Soluble in dimethyl sulfoxide
Form	Powder
Storage condition	-20°C

Trelagliptin Succinate, trade name Zafatek, is used to treat type 2 diabetes. Trelagliptin controls blood glucose levels by selectively and continuously inhibiting DPP-4. It is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor. Trelagliptin is the first anti-diabetic drug marketed in the world that is taken orally once a week, while similar DPP-4 inhibitors on the market need to be taken orally once a day. Zafatek’s drug advantages will undoubtedly provide a more convenient treatment option for diabetic patients. , is expected to significantly improve patient convenience and compliance.

Physical and chemical properties:

Trelagliptin succinate is white to off-white crystal or crystalline powder, easily soluble in water or dimethyl sulfoxide, slightly soluble in methanol, slightly soluble in ethanol (99.5), tetrahydrofuran or diethylamine, and Very slightly soluble in acetonitrile or 2-propanol.

Package and transportation :

Package: 5g,25g,200g,500g,1kg